Expansion of NK cells from cord blood with antileukemic activity using GMP-compliant substances without feeder cells (Q82816617)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143670%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Expansion of NK cells from cord blood with antileukemic activity using GMP-compliant substances without feeder cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143670%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

J Tanaka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143670%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

J Sugita

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143670%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

S Shiratori

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143670%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

A Shigematu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143670%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

S Asanuma

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143670%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

K Fujimoto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143670%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

M Nishio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143670%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

T Kondo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143670%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

M Imamura

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143670%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

6 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143670%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143670%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143670%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143670%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

1149-1152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22143670%20AND%20SRC:MED&resulttype=core&format=json

Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.345

7 January 2021

Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.345

7 January 2021

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.345

7 January 2021

FK506 causes cellular and functional defects in human natural killer cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.345

7 January 2021

The immunosuppressive agent FK506 enhances the cytolytic activity of inhibitory natural killer cell receptor (CD94/NKG2A)-expressing CD8 T cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.345

7 January 2021

The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.345

7 January 2021

Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.345

7 January 2021

High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.345

7 January 2021

Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.345

7 January 2021

Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.345

7 January 2021

Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.345

7 January 2021

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.345

7 January 2021

Infusion of allogeneic natural killer cells in a patient with acute myeloid leukemia in relapse after haploidentical hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.345

7 January 2021

Generation of donor natural killer cells from CD34(+) progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.345

7 January 2021